Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/24 17:20 | 5/13/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Gill David N | CA | D | 1 | S.m | -131 | 12.64 | 0 | -10 | 34 | D | ||||||||||||||||
5/15/24 17:19 | 5/13/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Malik Vikram | CA | D | 1 | S | -362 | 12.93 | 0 | -28 | 254 | D | ||||||||||||||||
5/14/24 20:56 | 5/10/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Moatazedi David | CA | DO | See Rema | 3 | S | -1,635 | 13.76 | 0 | -119 | 696 | D | |||||||||||||||
5/14/24 20:56 | 5/10/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Avelar Rui | CA | O | See Rema | 2 | S | -428 | 13.79 | 0 | -31 | 372 | D | |||||||||||||||
5/14/24 20:55 | 5/10/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Beaver Sandra | CA | O | CFO | 2 | S | -110 | 13.56 | 0 | -8 | 154 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |